A study from the University of Maryland, Baltimore County (UMBC), published in Nature Communications, reveals how ...

(WKBN) – Every year, thousands of people die from overdosing on opioids in the U.S. but now there’s a new, non-opioid pain ...

Health Affairs' Senior Deputy Editor Rob Lott interviews Jihye Han of Brigham and Women's Hospital and Harvard University on her recent paper that takes a closer look at the regulatory treatments for ...

This Nature Outlook is editorially independent, produced with financial support from Avadel. Miranda cannot remember a time in her life when she did not have insomnia. The 23 year old, who asked for ...

President Donald Trump said Monday that the White House is “very strongly” considering signing an executive order to ...

In 22.2% of trials, there was a survival benefit with the next-in-class agent. Less than one-quarter of next-in-class cancer drugs demonstrated a survival benefit over existing in-class agents in head ...

A new class of weight loss drugs are powering massive stock market gains for Novo Nordisk and Eli Lilly. Both stocks surged more than 16% on Tuesday, boosting the combined valuation of both companies ...

Researchers looked specifically at head-to-head randomized clinical trials of next-in-class cancer drugs against existing agents in the same class. Less than one-quarter of next-in-class cancer drugs ...